Accelerating Precision Medicine? Elementary My Dear Watson

Big-DataOne of my favorite life sciences industry media channels, BioPharma Dive, had a story this week about a new collaboration between IBM’s Watson Health division and 14 major oncology centers nationwide. The alliance is focused on bringing unprecedented analytics technology to cancer genomics.

The potential of this kind of collaboration on the growth of precision medicine, and its impact on the oncology market is exciting. Watson isn’t just for beating humans at Jeopardy!  It is now a core part of IBMs strategic vision in a number of different markets, including life sciences. Continue reading

Is This the Most Powerful Clinical Research Tool Ever Invented?

iPhoneMuch has been written over the past few months about Apple ResearchKit and its potential to completely revolutionize R&D in the life sciences industry. The idea is simple. And it got me thinking; is the iPhone the most powerful clinical research tool ever invented?

Apple’s ResearchKit uses an open source technology framework to allow research institutions running clinical trials to design apps that tap into the iPhone’s many sensors to collect and send data. With ResearchKit, the iPhone becomes a clincial research tool that can measure vital signs, share patient-reported outcomes, and harvest information. The technology will enable people to opt in to clinical trials from anywhere in the world. The iPhone also then becomes a powerful diagnostic tool that will enable vital information to be shared with physicians, hospitals, health centers, and more. This is, in my opinion, a new frontier for mHealth; one that is both exciting and thought provoking at the same time. Apple ResearchKit has the potential to transform entire industries including outsourced clinical research, diagnostics and drug development. But it is very early days.

Continue reading

Pharmaceutical Companies and mHealth: Where are the Opportunities?

mHealthMobile health, digital health and big data analytics are real growth areas, impacting all aspects of the healthcare ecosystem and changing how we deliver healthcare, manage our individual health, pay for services and access health related information, among other things. But where do pharmaceutical companies fit into the equation, and how can the pharmaceutical industry benefit from the revolution happening in mHealth?

Continue reading

Cool Facts About Big Data in Healthcare



We are at a tipping point in the developed world where our ability to generate, analyze, interpret and act upon data is transforming multiple industries, governments and societies. Big Data is big business. In healthcare, Big Data holds enormous promise, and we’re already seeing its impact in areas such as precision medicine, biopharmaceutical R&D productivity, mobile health, telemedicine and more.

Continue reading

Telehealth and the Internet of Things

internet-of-thingsI recently had a very interesting conversation with a telehealth thought leader. We discussed the amazing changes taking place in healthcare in the United States, and the key role that telehealth is going to play in the future. We also talked about the importance of the Internet of Things and healthcare. 

Continue reading

Personalized Medicine and a Cure for Cancer


This week we had a double dose of news about the fight against cancer. And there is more to come, as two major medical conferences take place almost simultaneously. Leading cancer doctors, researchers and members of the life sciences community are excited about the possibilities of immunotherapy in the treatment of cancer. Immunotherapy, where the body’s own immune system is enlisted to fight cancer, is an example of the kinds of advances being made in personalized medicine.

Continue reading

MANA 2015 Healthcare Marketing Report


Healthcare in the United States is in a transformational period. The Affordable Care Act, an explosion in new medical technologies, and the emergence of personalized medicine as a new model for healthcare delivery are all contributing to massive changes. In our free report, written specifically for those of us working in healthcare marketing, we take a look at some of these areas to identify what healthcare marketers will be facing in 2015.

We are very passionate about the industries and the clients we serve, and we believe that it is an incredibly challenging and exciting time for healthcare marketers as the U.S. healthcare system goes through a period of unprecedented change.

Continue reading

Personalized Medicine: Reimbursement and Marketing Challenges

personalized_medicineWe are undoubtedly in the midst of major change in how healthcare is delivered, measured and paid for. As with all periods of great change, there are going to be winners and losers. One area I’ve been bullish about for a few years now is diagnostics and personalized medicine. As the US healthcare system moves from a volume based model to a value and outcomes based model, the ability to deliver the right treatment to the right patient at the right time means that personalized medicine, and the diagnostic products and services that make it possible, has an opportunity to be a real winner. The growth statistics and forecasts for this dynamic market sector make for interesting reading.

Continue reading

Dementia–A Real Healthcare Crisis for the Pharmaceutical Industry

DementiaThis morning I read a very sad story in the excellent British newspaper The Telegraph. David Cameron, Prime Minister of the United Kingdom, described the “desperate sadness” he felt as he watched Margaret Thatcher, a brilliant politician and one of the UK’s great leaders who he saw at the height of her powers, slip away with the onset and progression of dementia.

The United Kingdom is in the midst of a national debate on dementia as the result of a recent report from the Care Quality Commission (CQC), the independent regulator of health and social care in England. The report found major shortcomings in the quality of care provided to those suffering from dementia across the country. Continue reading

Big Data Analytics Gets a Big Nod from NIH

NIH_LogoThere was great news yesterday from the National Institutes of Health (NIH), especially for those of us who support Big Data analytics as having a major role to play in fixing some of what’s broken in healthcare. The NIH announced an initial investment of almost $32 million during fiscal year 2014 in awards to multiple institutes working on challenges related to Big Data analytics in healthcare. This investment is part of the NIH’s Big Data to Knowledge (BD2K) initiative, which is projected to have a total investment of nearly $656 million through 2020, pending available funds.

Continue reading

Wearable Health Devices, Healthcare Costs and Big Data Companies

MedCity News today shared some interesting healthcare technology news: 100 million wearable health devices will be shipped over the next five years, according to ABI Research. This market is booming due in large part to the growing interest in the potential to move non-critical care out of the hospitals and into patient’s homes.

Continue reading